{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237604,Language='FR')/Transcripts"}},"ID":20237604,"Language":"FR","BusinessShortNumber":"23.7604","BusinessType":14,"BusinessTypeName":"Heure des questions. Question","BusinessTypeAbbreviation":"Qst.","Title":"D\u00e9pistage \u00e0 domicile des IST: quelles cons\u00e9quences au rigorisme r\u00e9glementaire de Swissmedic sur la sant\u00e9 publique?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"

Cet \u00e9t\u00e9, Swissmedic a inform\u00e9 l\u2019Aide Suisse contre le Sida que tout pr\u00e9l\u00e8vement par frottis pour le d\u00e9pistage de la gonorrh\u00e9e et chlamydia devait imp\u00e9rativement \u00eatre r\u00e9alis\u00e9 par du personnel m\u00e9dical pour \u00eatre conforme. En sus, la technique du pooling est aussi proscrite.

Ces mesures entra\u00eeneront une augmentation des co\u00fbts de la sant\u00e9, mais surtout une diminution annonc\u00e9e des d\u00e9pistages: quelles mesures le Conseil f\u00e9d\u00e9ral va-t-il prendre pour att\u00e9nuer les risques sanitaires que cela repr\u00e9sente?

","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"

Les produits de pr\u00e9l\u00e8vement d'\u00e9chantillons et les tests de d\u00e9pistage des maladies transmissibles doivent, en tant que dispositifs m\u00e9dicaux de diagnostic in vitro, \u00eatre conformes \u00e0 la l\u00e9gislation sur les produits th\u00e9rapeutiques. Des tests non conformes et une utilisation incorrecte peuvent conduire \u00e0 des r\u00e9sultats faussement n\u00e9gatifs.

Dans le cas concret, Swissmedic a constat\u00e9 lors d\u2019une proc\u00e9dure de surveillance du march\u00e9 que l\u2019Aide Suisse contre le Sida a distribu\u00e9 au sein de la population du mat\u00e9riel de pr\u00e9l\u00e8vement destin\u00e9 et certifi\u00e9 pour \u00eatre utilis\u00e9 uniquement par des professionnels de la sant\u00e9. Swissmedic est en contact \u00e9troit avec le prestataire afin de trouver une solution qui soit viable et conforme aux dispositions l\u00e9gales actuelles.

 

Du point de vue de la sant\u00e9 publique, il importe que les infections sexuellement transmissibles (IST) soient d\u00e9tect\u00e9es le plus t\u00f4t possible afin de traiter rapidement les personnes touch\u00e9es et d\u2019\u00e9viter de nouvelles transmissions. Dans cette optique, il est donc souhaitable que des tests facilement accessibles et financi\u00e8rement abordables soient propos\u00e9s aux personnes expos\u00e9es \u00e0 un risque d\u2019IST. Il s\u2019agit d\u2019une pr\u00e9occupation centrale dans le programme national que l\u2019Office f\u00e9d\u00e9ral de la sant\u00e9 publique conduit et conduira encore contre le VIH, les IST et les h\u00e9patites virales.

","FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1694995200000)\/","SubmittedBy":"Porchet L\u00e9onore","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1695055993000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"28|2841","Category":null,"Modified":"\/Date(1763100488000)\/","SubmissionDate":"\/Date(1694563200000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5122,"SubmissionLegislativePeriod":51,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Questions sociales|Sant\u00e9"}}